Imidazole Variants as Modulators of Gaba Receptor For the Treatment of Gi Disorders
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to novel compounds having a positive allosteric GÀBAB receptor (GDR) modulator effect, methods for the preparation of said compounds and to their use, optionally in combination with a GABAB agonist, for the inhibition of transient lower esophageal sphincter relaxations, for the treatment of gastroesophageal reflux disease, as well as for the treatment of functional gastrointestinal disorders and irritable bowel syndrome (IBS). A compound of the general formula I
25 Citations
36 Claims
- 1. A compound of the general formula I,
-
14. (canceled)
-
17-25. -25. (canceled)
-
36. A compound of formula II,
Specification